Medexus Pharmaceuticals Inc (MDP.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 2,428 | 2,426 | 2,436 | 1,756 | 1,576 |
| Income taxes - deferred | -12 | 99 | -206 | 147 | -691 |
| Accounts receivable | 244 | 1,077 | 799 | -1,248 | 252 |
| Other Working Capital | -290 | 580 | 619 | 1,294 | 1,546 |
| Other Operating Activity | 967 | -263 | -1,372 | 4,761 | 4,172 |
| Operating Cash Flow | $3,337 | $3,919 | $2,276 | $6,710 | $6,855 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -7 | -125 | -53 | -61 | -37 |
| Net Acquisitions | -1,648 | -369 | -2,010 | -375 | -445 |
| Purchase Sale Intangibles | N/A | N/A | 0 | -43 | -2,500 |
| Other Investing Activity | 0 | -1,847 | 0 | 0 | 0 |
| Investing Cash Flow | $-1,655 | $-2,341 | $-2,063 | $-479 | $-2,982 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -1,157 | -15,552 | -3,357 | -3,359 | -4,161 |
| Common Stock Issued | N/A | N/A | 19,162 | 0 | N/A |
| Other Financing Activity | -442 | -739 | -639 | -1,102 | -1,253 |
| Financing Cash Flow | $-1,599 | $-16,291 | $15,166 | $-4,461 | $-5,414 |
| Exchange Rate Effect | -34 | 72 | 153 | -302 | 60 |
| Beginning Cash Position | 9,332 | 23,973 | 8,441 | 6,973 | 8,454 |
| End Cash Position | 9,381 | 9,332 | 23,973 | 8,441 | 6,973 |
| Net Cash Flow | $83 | $-14,713 | $15,379 | $1,770 | $-1,541 |
| Free Cash Flow | |||||
| Operating Cash Flow | 3,337 | 3,919 | 2,276 | 6,710 | 6,855 |
| Capital Expenditure | -7 | -125 | -53 | -104 | -2,537 |
| Free Cash Flow | 3,330 | 3,794 | 2,223 | 6,606 | 4,318 |